Associations between schizophrenia genetic risk, anxiety disorders and manic/hypomanic episode in a longitudinal population cohort study.


Journal

The British journal of psychiatry : the journal of mental science
ISSN: 1472-1465
Titre abrégé: Br J Psychiatry
Pays: England
ID NLM: 0342367

Informations de publication

Date de publication:
02 2019
Historique:
pubmed: 27 11 2018
medline: 1 2 2020
entrez: 27 11 2018
Statut: ppublish

Résumé

Studies involving clinically recruited samples show that genetic liability to schizophrenia overlaps with that for several psychiatric disorders including bipolar disorder, major depression and, in a population study, anxiety disorder and negative symptoms in adolescence.AimsWe examined whether, at a population level, association between schizophrenia liability and anxiety disorders continues into adulthood, for specific anxiety disorders and as a group. We explored in an epidemiologically based cohort the nature of adult psychopathology sharing liability to schizophrenia. Schizophrenia polygenic risk scores (PRSs) were calculated for 590 European-descent individuals from the Christchurch Health and Development Study. Logistic regression was used to examine associations between schizophrenia PRS and four anxiety disorders (social phobia, specific phobia, panic disorder and generalised anxiety disorder), schizophrenia/schizophreniform disorder, manic/hypomanic episode, alcohol dependence, major depression, and - using linear regression - total number of anxiety disorders. A novel population-level association with hypomania was tested in a UK birth cohort (Avon Longitudinal Study of Parents and Children). Schizophrenia PRS was associated with total number of anxiety disorders and with generalised anxiety disorder and panic disorder. We show a novel population-level association between schizophrenia PRS and manic/hypomanic episode. The relationship between schizophrenia liability and anxiety disorders is not restricted to psychopathology in adolescence but is present in adulthood and specifically linked to generalised anxiety disorder and panic disorder. We suggest that the association between schizophrenia liability and hypomanic/manic episodes found in clinical samples may not be due to bias.Declarations of interestNone.

Sections du résumé

BACKGROUND
Studies involving clinically recruited samples show that genetic liability to schizophrenia overlaps with that for several psychiatric disorders including bipolar disorder, major depression and, in a population study, anxiety disorder and negative symptoms in adolescence.AimsWe examined whether, at a population level, association between schizophrenia liability and anxiety disorders continues into adulthood, for specific anxiety disorders and as a group. We explored in an epidemiologically based cohort the nature of adult psychopathology sharing liability to schizophrenia.
METHOD
Schizophrenia polygenic risk scores (PRSs) were calculated for 590 European-descent individuals from the Christchurch Health and Development Study. Logistic regression was used to examine associations between schizophrenia PRS and four anxiety disorders (social phobia, specific phobia, panic disorder and generalised anxiety disorder), schizophrenia/schizophreniform disorder, manic/hypomanic episode, alcohol dependence, major depression, and - using linear regression - total number of anxiety disorders. A novel population-level association with hypomania was tested in a UK birth cohort (Avon Longitudinal Study of Parents and Children).
RESULTS
Schizophrenia PRS was associated with total number of anxiety disorders and with generalised anxiety disorder and panic disorder. We show a novel population-level association between schizophrenia PRS and manic/hypomanic episode.
CONCLUSIONS
The relationship between schizophrenia liability and anxiety disorders is not restricted to psychopathology in adolescence but is present in adulthood and specifically linked to generalised anxiety disorder and panic disorder. We suggest that the association between schizophrenia liability and hypomanic/manic episodes found in clinical samples may not be due to bias.Declarations of interestNone.

Identifiants

pubmed: 30472973
pii: S0007125018002271
doi: 10.1192/bjp.2018.227
pmc: PMC6429243
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

96-102

Subventions

Organisme : Medical Research Council
ID : G0801418
Pays : United Kingdom
Organisme : NIDA NIH HHS
ID : R01 DA024413
Pays : United States
Organisme : Medical Research Council
ID : MR/L010305/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0800509
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/P005748/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G9815508
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 102215/2/13/2
Pays : United Kingdom

Références

Clin Pract Epidemiol Ment Health. 2006 Mar 08;2:2
pubmed: 16524481
Lancet Psychiatry. 2017 Jan;4(1):57-62
pubmed: 27932233
Compr Psychiatry. 2014 Jul;55(5):1310-21
pubmed: 24746530
Schizophr Bull. 2016 May;42(3):832-42
pubmed: 26678674
Int J Epidemiol. 2013 Feb;42(1):111-27
pubmed: 22507743
Am J Hum Genet. 2017 Apr 6;100(4):635-649
pubmed: 28366442
Transl Psychiatry. 2016 Nov 1;6(11):e938
pubmed: 27801894
Int J Epidemiol. 2013 Feb;42(1):97-110
pubmed: 22507742
Arch Gen Psychiatry. 2011 Aug;68(8):791-8
pubmed: 21810644
J Affect Disord. 2009 Apr;114(1-3):68-73
pubmed: 18760487
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
Br J Psychiatry. 2011 Feb;198(2):129-35
pubmed: 21282783
Am J Med Genet. 2000 Spring;97(1):12-7
pubmed: 10813800
Nat Rev Genet. 2012 Jul 10;13(8):537-51
pubmed: 22777127
Aust N Z J Psychiatry. 2001 Jun;35(3):287-96
pubmed: 11437801
J Affect Disord. 2014 Jan;152-154:448-53
pubmed: 24210625
JAMA Psychiatry. 2016 Mar;73(3):221-8
pubmed: 26818099
Nature. 2014 Jul 24;511(7510):421-7
pubmed: 25056061
Proc Natl Acad Sci U S A. 1967 Jul;58(1):199-205
pubmed: 5231600
Schizophr Bull. 2009 Mar;35(2):383-402
pubmed: 19011234
Twin Res Hum Genet. 2015 Aug;18(4):335-47
pubmed: 26081443
Lancet. 2013 Apr 20;381(9875):1371-1379
pubmed: 23453885
Nature. 2009 Aug 6;460(7256):748-52
pubmed: 19571811
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245

Auteurs

Alexander Richards (A)

Research Associate,Division of Psychological Medicine and Clinical Neurosciences,Cardiff University,UK.

John Horwood (J)

Professor, Christchurch Health and Development Study,Department of Psychological Medicine, University of Otago Christchurch,New Zealand.

Joseph Boden (J)

Associate Professor,Christchurch Health and Development Study, Department of Psychological Medicine,University of Otago Christchurch,New Zealand.

Martin Kennedy (M)

Professor,Department of Pathology,University of Otago Christchurch,New Zealand.

Ruth Sellers (R)

Economic and Social Research Council Future Research Leader Fellow,Division of Psychological Medicine and Clinical Neurosciences,Cardiff University and School of Psychology, University of Sussex,UK.

Lucy Riglin (L)

Research Associate,Division of Psychological Medicine and Clinical Neurosciences,Cardiff University,UK.

Sumit Mistry (S)

Division of Psychological Medicine and Clinical Neurosciences,Cardiff University,UK.

Hannah Jones (H)

Research Associate,Population Health Sciences,Bristol Medical School and Medical Research Council Integrative Epidemiology Unit,University of Bristol,UK.

Daniel J Smith (DJ)

Professor,Institute of Health and Wellbeing,University of Glasgow,UK.

Stanley Zammit (S)

Professor,Division of Psychological Medicine and Clinical Neurosciences,Cardiff University and Population Health Sciences, Bristol Medical School, University of Bristol,UK.

Michael Owen (M)

Professor,Division of Psychological Medicine and Clinical Neurosciences,Cardiff University,UK.

Michael C O'Donovan (MC)

Professor,Division of Psychological Medicine and Clinical Neurosciences,Cardiff University,UK.

Gordon T Harold (GT)

Professor,Division of Psychological Medicine and Clinical Neurosciences,Cardiff University and School of Psychology, University of Sussex and School of Psychology,Trinity College,UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH